Literature DB >> 9358200

Changes in cyclosporine A kinetics after experimental reduction of renal parenchyma.

O Schück1, M Bohdanecká, J Sedivý, M Krajícková, M Chadimová, K Matousovic.   

Abstract

Experimental chronic renal insufficiency (produced by 5/6 ablation of renal parenchyma) is associated with changes in the kinetics of oral (intragastric) cyclosporine A (CyA). Compared with animals with intact renal parenchyma, significantly lower levels of CyA are reached under these conditions. The factors responsible for reduced CyA availability under these conditions have not yet been identified.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358200     DOI: 10.1007/BF03189808

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  5 in total

Review 1.  Significance of cyclosporine pharmacokinetics.

Authors:  J Grevel
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

2.  Experimental modeling of the effect of uremia on cyclosporin A bioavailability.

Authors:  M Bohdanecká; O Schück; R Petrásek; J Sedivy; V Reitschlägerová
Journal:  Int J Clin Pharmacol Ther       Date:  1995-01       Impact factor: 1.366

3.  Excretion of cyclosporine and its metabolites in human bile.

Authors:  G J Burckart; T E Starzl; R Venkataramanan; H Hashim; L Wong; P Wang; L Makowka; A Zeevi; R J Ptachcinski; J E Knapp
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

4.  Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay.

Authors:  B D Kahan; W G Kramer; C Wideman; S M Flechner; M I Lorber; C T Van Buren
Journal:  Transplantation       Date:  1986-04       Impact factor: 4.939

5.  Intravenous cyclosporine kinetics in renal failure.

Authors:  F Follath; M Wenk; S Vozeh; G Thiel; F Brunner; R Loertscher; M Lemaire; K Nussbaumer; W Niederberger; A Wood
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.